Literature DB >> 28811998

Paracoccidioidomycosis: level of pulmonary sequelae in high resolution computed tomography images from patients of two endemic regions of Brazil.

Diana Rodrigues de Pina1, Matheus Alvarez2, Guilherme Giacomini2, Ana Luiza Menegatti Pavan2, Carlos Ivan Andrade Guedes3, Ricardo de Souza Cavalcante1, Rinaldo Poncio Mendes1, Anamaria Mello Miranda Paniago3.   

Abstract

BACKGROUND: The purpose of the present study was to evaluate differences in lung damage in patients with paracoccidioidomycosis (PCM) in two endemic regions of Brazil (Botucatu, SP, in the southeastern region and Campo Grande, MS, in the west central region).
METHODS: The study sought to objectively quantify fibrosis and emphysema treated patients using high-resolution computed tomography (HRCT) that was performed according to an established and validated computational method. The analysis was based on clinical data that were associated with objective quantifications of pulmonary sequelae. We performed a retrospective analysis of HRCT exams from 32 successfully treated patients with the chronic form of PCM. The two groups had similar characteristics with regard to age, symptom duration, smoking history, and titers on a diagnostic serologic test.
RESULTS: The statistical analysis revealed more severe cases and a higher percentage of emphysema in the Campo Grande group. The mean percentages of emphysema were 40.2% and 13.6% in the Campo Grande and Botucatu groups, respectively. The percentage of fibrosis was significantly higher in the Botucatu group (11.3%) than in the Campo Grande group (2.3%).
CONCLUSIONS: The present results may reflect differences in cryptic species of P. brasiliensis in these two geographic regions of Brazil. Further studies should be done to clarify the differences observed herein. Such findings may help unveil differences among cryptic species in terms of the pulmonary consequences that are caused by this disease, which would be highly beneficial to PCM patients.

Entities:  

Keywords:  Cryptic species; emphysema; fibrosis; paracoccidioidomycosis (PCM); quantification; tissue

Year:  2017        PMID: 28811998      PMCID: PMC5537134          DOI: 10.21037/qims.2017.06.04

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  30 in total

Review 1.  Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues.

Authors:  Anamelia Lorenzetti Bocca; André Corrêa Amaral; Marcus Melo Teixeira; Paula Keiko Sato; Paula Sato; Maria Aparecida Shikanai-Yasuda; Maria Sueli Soares Felipe
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

Review 2.  Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.

Authors:  Andrew L Ries; Gerene S Bauldoff; Brian W Carlin; Richard Casaburi; Charles F Emery; Donald A Mahler; Barry Make; Carolyn L Rochester; Richard Zuwallack; Carla Herrerias
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

3.  Paracoccidioidomycosis mortality in Brazil (1980-1995).

Authors:  Ziadir Francisco Coutinho; Delson da Silva; Márcia Lazera; Valéria Petri; Rosely Magalhães de Oliveira; Paulo C Sabroza; Bodo Wanke
Journal:  Cad Saude Publica       Date:  2002 Sep-Oct       Impact factor: 1.632

4.  Pathology of the human pulmonary paracoccidioidomycosis.

Authors:  R M Tuder; R el Ibrahim; C E Godoy; T De Brito
Journal:  Mycopathologia       Date:  1985-12       Impact factor: 2.574

5.  Paracoccidioides lutzii sp. nov.: biological and clinical implications.

Authors:  Marcus de Melo Teixeira; Raquel Cordeiro Theodoro; Fabiana Freire Mendes de Oliveira; Gabriel Capella Machado; Rosane Christine Hahn; Eduardo Bagagli; Gioconda San-Blas; Maria Sueli Soares Felipe
Journal:  Med Mycol       Date:  2014-01       Impact factor: 4.076

Review 6.  An overview of the immunopathology of human paracoccidioidomycosis.

Authors:  Gil Benard
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

7.  Objective CT-based quantification of lung sequelae in treated patients with paracoccidioidomycosis.

Authors:  Matheus Alvarez; Diana R Pina; Marcela de Oliveira; Sérgio M Ribeiro; Rinaldo P Mendes; Sérgio B Duarte; José R A Miranda
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

8.  Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis.

Authors:  Ricardo de Souza Cavalcante; Tatiane Fernanda Sylvestre; Adriele Dandara Levorato; Lídia Rachel de Carvalho; Rinaldo Poncio Mendes
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

9.  Paracoccidioidomycosis in southern Rio Grande do Sul: a retrospective study of histopathologically diagnosed cases.

Authors:  Silvana Pereira de Souza; Valéria Magalhães Jorge; Melissa Orzechowski Xavier
Journal:  Braz J Microbiol       Date:  2014-05-19       Impact factor: 2.476

10.  Serology of paracoccidioidomycosis due to Paracoccidioides lutzii.

Authors:  Gregory Gegembauer; Leticia Mendes Araujo; Edy Firmina Pereira; Anderson Messias Rodrigues; Anamaria Mello Miranda Paniago; Rosane Christine Hahn; Zoilo Pires de Camargo
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.